{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:09:18Z","timestamp":1778746158217,"version":"3.51.4"},"reference-count":83,"publisher":"Tsinghua University Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.26599\/1671-5411.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:11:58Z","timestamp":1778742718000},"page":"152-172","source":"Crossref","is-referenced-by-count":0,"title":["Neurodegenerative biomarkers and heart failure: is there a neurodegenerative cardiomyopathy? a systematic review and meta-analysis"],"prefix":"10.26599","volume":"23","author":[{"given":"Arveen","family":"Shokravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"LUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon W.","family":"Rabkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1111\/jgs.18467","article-title":"Heart failure with comorbid dementia: Association with clinical characteristics and outcomes","volume":"71","author":"MS Jensen","year":"2023","unstructured":"MS Jensen. Heart failure with comorbid dementia: Association with clinical characteristics and outcomes. 2023, 71: 3172-3178.","journal-title":"J Am Geriatr Soc;"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cardfail.2024.01.003","article-title":"Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement","volume":"30","author":"P Goyal","year":"2024","unstructured":"P Goyal. Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement. 2024, 30: 488-504.","journal-title":"J Card Fail;"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.1532-5415.2012.04097.x","article-title":"Prevalence of cognitive impairment in older adults with heart failure","volume":"60","author":"TR Gure","year":"2012","unstructured":"TR Gure. Prevalence of cognitive impairment in older adults with heart failure. 2012, 60: 1724-1729.","journal-title":"J Am Geriatr Soc;"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12872-019-1077-4","article-title":"Self-management of heart failure in dementia and cognitive impairment: a systematic review","volume":"19","author":"J Lovell","year":"2019","unstructured":"J Lovell. Self-management of heart failure in dementia and cognitive impairment: a systematic review. 2019, 19: 99.","journal-title":"BMC Cardiovasc Disord;"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/jgs.17752","article-title":"Alzheimer\u2019s disease and related dementias and heart failure: A community study","volume":"70","author":"SM Manemann","year":"2022","unstructured":"SM Manemann. Alzheimer\u2019s disease and related dementias and heart failure: A community study. 2022, 70: 1664-1672.","journal-title":"J Am Geriatr Soc;"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10741-015-9471-1","article-title":"The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic review and meta-analysis","volume":"20","author":"B Chow","year":"2015","unstructured":"B Chow. The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic review and meta-analysis. 2015, 20: 291-303.","journal-title":"Heart Fail Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/JAD-2012-120757","article-title":"Arterial stiffness: Detection and consequences in cognitive impairment and dementia of the elderly","volume":"32","author":"SW Rabkin","year":"2012","unstructured":"SW Rabkin. Arterial stiffness: Detection and consequences in cognitive impairment and dementia of the elderly. 2012, 32: 541-549.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"ref8","first-page":"5961","article-title":"Collagen type IV as the link between arterial stiffness and dementia","volume":"15","author":"SW Rabkin","year":"2023","unstructured":"SW Rabkin. Collagen type IV as the link between arterial stiffness and dementia. 2023, 15: 5961-5971.","journal-title":"Am J Transl Res;"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12471-012-0348-9","article-title":"The heart-brain connection: mechanistic insights and models","volume":"21","author":"K Ritz","year":"2013","unstructured":"K Ritz. The heart-brain connection: mechanistic insights and models. 2013, 21: 55-57.","journal-title":"Neth Heart J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s11886-023-01990-8","article-title":"The Brain-Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease","volume":"25","author":"J-R Hu","year":"2023","unstructured":"J-R Hu. The Brain-Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease. 2023, 25: 1745-1758.","journal-title":"Curr Cardiol Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3233\/JAD-2010-091561","article-title":"Cardiac disorders as risk factors for Alzheimer\u2019s disease","volume":"20","author":"TC de Toledo Ferraz Alves","year":"2010","unstructured":"TC de Toledo Ferraz Alves. Cardiac disorders as risk factors for Alzheimer\u2019s disease. 2010, 20: 749-763.","journal-title":"J Alzheimers Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.1007\/s12035-019-01655-0","article-title":"Neurocognitive disorders in heart failure: novel pathophysiological mechanisms underpinning memory loss and learning impairment","volume":"56","author":"C Toledo","year":"2019","unstructured":"C Toledo. Neurocognitive disorders in heart failure: novel pathophysiological mechanisms underpinning memory loss and learning impairment. 2019, 56: 8035-8051.","journal-title":"Mol Neurobiol;"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1494101","DOI":"10.3389\/fmed.2025.1494101","article-title":"Amyloid-\u03b2 and heart failure in Alzheimer\u2019s disease: the new vistas","volume":"12","author":"HM Al-Kuraishy","year":"2025","unstructured":"HM Al-Kuraishy. Amyloid-\u03b2 and heart failure in Alzheimer\u2019s disease: the new vistas. 2025, 12: 1494101.","journal-title":"Front Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.3346\/jkms.2023.38.e334","article-title":"A Correlative Relationship Between Heart Failure and Cognitive Impairment: A Narrative Review","volume":"38","author":"MS Park","year":"2023","unstructured":"MS Park. A Correlative Relationship Between Heart Failure and Cognitive Impairment: A Narrative Review. 2023, 38: e334.","journal-title":"J Korean Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics","volume":"140","author":"SA Kent","year":"2020","unstructured":"SA Kent. The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. 2020, 140: 417-447.","journal-title":"Acta Neuropathol;"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"A Demuro","year":"2010","unstructured":"A Demuro. Calcium signaling and amyloid toxicity in Alzheimer disease. 2010, 285: 12463-12468.","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1081938","DOI":"10.3389\/fnins.2023.1081938","article-title":"Amyloid-beta aggregation implicates multiple pathways in Alzheimer\u2019s disease: Understanding the mechanisms","volume":"17","author":"MO Iliyasu","year":"2023","unstructured":"MO Iliyasu. Amyloid-beta aggregation implicates multiple pathways in Alzheimer\u2019s disease: Understanding the mechanisms. 2023, 17: 1081938.","journal-title":"Front Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1007\/s00018-014-1706-0","article-title":"Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer\u2019s disease","volume":"71","author":"TI Kam","year":"2014","unstructured":"TI Kam. Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer\u2019s disease. 2014, 71: 4803-4813.","journal-title":"Cell Mol Life Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease","volume":"19","author":"L Crews","year":"2010","unstructured":"L Crews. Molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease. 2010, 19: R12-R20.","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainresbull.2022.10.006","article-title":"The central role of tau in Alzheimer\u2019s disease: From neurofibrillary tangle maturation to the induction of cell death","volume":"190","author":"DR Thal","year":"2022","unstructured":"DR Thal. The central role of tau in Alzheimer\u2019s disease: From neurofibrillary tangle maturation to the induction of cell death. 2022, 190: 204-217.","journal-title":"Brain Res Bull"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.3390\/ijms22179207","article-title":"Tau Protein Interaction Partners and Their Roles in Alzheimer\u2019s Disease and Other Tauopathies","volume":"22","author":"J Sinsky","year":"2021","unstructured":"J Sinsky. Tau Protein Interaction Partners and Their Roles in Alzheimer\u2019s Disease and Other Tauopathies. 2021, 22: 9207.","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnins.2018.00441","article-title":"Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration","volume":"12","author":"MJ P\u00e9rez","year":"2018","unstructured":"MJ P\u00e9rez. Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration. 2018, 12: 441.","journal-title":"Front Neurosci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"573324","DOI":"10.3389\/fneur.2020.573324","article-title":"Impact of Tau on Neurovascular Pathology in Alzheimer\u2019s Disease","volume":"11","author":"E Canepa","year":"2020","unstructured":"E Canepa. Impact of Tau on Neurovascular Pathology in Alzheimer\u2019s Disease. 2020, 11: 573324.","journal-title":"Front Neurol;"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders","volume":"57","author":"Z Alirezaei","year":"2020","unstructured":"Z Alirezaei. Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders. 2020, 57: 469-491.","journal-title":"Mol Neurobiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/brain\/awae211","article-title":"Association of glial fibrillary acid protein, Alzheimer\u2019s disease pathology and cognitive decline","volume":"147","author":"DE Peretti","year":"2024","unstructured":"DE Peretti. Association of glial fibrillary acid protein, Alzheimer\u2019s disease pathology and cognitive decline. 2024, 147: 4094-4104.","journal-title":"Brain"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awae035","article-title":"Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles","volume":"147","author":"P S\u00e1nchez-Juan","year":"2024","unstructured":"P S\u00e1nchez-Juan. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. 2024, 147: 1667-1679.","journal-title":"Brain"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/ejn.15914","article-title":"TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer\u2019s disease treatment","volume":"57","author":"G Ayyubova","year":"2023","unstructured":"G Ayyubova. TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer\u2019s disease treatment. 2023, 57: 718-733.","journal-title":"Eur J Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.01.031","author":"","unstructured":"","journal-title":"null"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","article-title":"New insights into the role of TREM2 in Alzheimer\u2019s disease","volume":"13","author":"M Gratuze","year":"2018","unstructured":"M Gratuze. New insights into the role of TREM2 in Alzheimer\u2019s disease. 2018, 13: 66.","journal-title":"Mol Neurodegener"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"101856","DOI":"10.1016\/j.arr.2023.101856","article-title":"Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury","volume":"86","author":"Z Mi","year":"2023","unstructured":"Z Mi. Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury. 2023, 86: 101856.","journal-title":"Ageing Res Rev"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","article-title":"YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies","volume":"14","author":"M Querol-Vilaseca","year":"2017","unstructured":"M Querol-Vilaseca. YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies. 2017, 14: 118.","journal-title":"J Neuroinflammation"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","article-title":"YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias","volume":"12","author":"F Llorens","year":"2017","unstructured":"F Llorens. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. 2017, 12: 83.","journal-title":"Mol Neurodegener"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12974-023-02970-z","article-title":"Astrocyte-specific knockout of YKL-40\/Chi3l1 reduces A\u03b2 burden and restores memory functions in 5xFAD mice","volume":"20","author":"X Zeng","year":"2023","unstructured":"X Zeng. Astrocyte-specific knockout of YKL-40\/Chi3l1 reduces A\u03b2 burden and restores memory functions in 5xFAD mice. 2023, 20: 290.","journal-title":"J Neuroinflammation"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"120551","DOI":"10.1016\/j.jns.2023.120551","article-title":"Cerebral amyloid-\u03b2 deposition in patients with heart disease or carotid occlusive disease: A systematic review and meta-analysis","volume":"445","author":"NLP Starmans","year":"2023","unstructured":"NLP Starmans. Cerebral amyloid-\u03b2 deposition in patients with heart disease or carotid occlusive disease: A systematic review and meta-analysis. 2023, 445: 120551.","journal-title":"J Neurol Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/10408363.2016.1190683","article-title":"Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases","volume":"53","author":"AD Kjaergaard","year":"2016","unstructured":"AD Kjaergaard. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. 2016, 53: 396-408.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"eaax4826","DOI":"10.1126\/sciadv.aax4826","article-title":"The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor","volume":"6","author":"HL Bi","year":"2020","unstructured":"HL Bi. The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor. 2020, 6: eaax4826.","journal-title":"Sci Adv"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/eurheartj\/ehad205","article-title":"Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy","volume":"44","author":"M Luciani","year":"2023","unstructured":"M Luciani. Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy. 2023, 44: 1560-1570.","journal-title":"Eur Heart J;"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"","unstructured":"","journal-title":"null"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/14017430903402218","article-title":"Plasma YKL-40 levels are elevated in patients with chronic heart failure","volume":"44","author":"CN Rathcke","year":"2010","unstructured":"CN Rathcke. Plasma YKL-40 levels are elevated in patients with chronic heart failure. 2010, 44: 92-99.","journal-title":"Scand Cardiovasc J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cardfail.2010.05.029","article-title":"Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure","volume":"16","author":"O Bilim","year":"2010","unstructured":"O Bilim. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure. 2010, 16: 873-879.","journal-title":"J Card Fail;"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.imbio.2011.11.003","article-title":"The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure","volume":"217","author":"M Harutyunyan","year":"2012","unstructured":"M Harutyunyan. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure. 2012, 217: 652-656.","journal-title":"Immunobiology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/1354750X.2016.1204003","article-title":"Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)","volume":"22","author":"F Arain","year":"2017","unstructured":"F Arain. Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA). 2017, 22: 261-267.","journal-title":"Biomarkers"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.rec.2017.02.021","article-title":"Bloodstream amyloid-beta (1-40) peptide, cognition, and outcomes in heart failure","volume":"70","author":"A Bayes-Genis","year":"2017","unstructured":"A Bayes-Genis. Bloodstream amyloid-beta (1-40) peptide, cognition, and outcomes in heart failure. 2017, 70: 924-932.","journal-title":"Rev Esp Cardiol (Engl Ed);"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e14920","DOI":"10.1097\/MD.0000000000014920","article-title":"Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"98","author":"L Yang","year":"2019","unstructured":"L Yang. Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. 2019, 98: e14920.","journal-title":"Medicine (Baltimore);"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jacc.2019.12.069","article-title":"Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction","volume":"75","author":"JA Chirinos","year":"2020","unstructured":"JA Chirinos. Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction. 2020, 75: 1281-1295.","journal-title":"J Am Coll Cardiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"111970","DOI":"10.1016\/j.diabres.2024.111970","article-title":"YKL-40, cardiovascular events, and mortality in individuals recently diagnosed with type 2 diabetes: A Danish cohort study","volume":"219","author":"AD Kjaergaard","year":"2025","unstructured":"AD Kjaergaard. YKL-40, cardiovascular events, and mortality in individuals recently diagnosed with type 2 diabetes: A Danish cohort study. 2025, 219: 111970.","journal-title":"Diabetes Res Clin Pract"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"H594","DOI":"10.1152\/ajpheart.00728.2024","article-title":"Plasma levels of sTREM2 in chronic heart failure: predictors and prognostic relevance","volume":"328","author":"J Traub","year":"2025","unstructured":"J Traub. Plasma levels of sTREM2 in chronic heart failure: predictors and prognostic relevance. 2025, 328: H594-H602.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13195-022-01087-4","article-title":"Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients","volume":"14","author":"J Traub","year":"2022","unstructured":"J Traub. Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients. 2022, 14: 149.","journal-title":"Alzheimers Res;"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1002\/ehf2.13986","article-title":"Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure","volume":"9","author":"J Traub","year":"2022","unstructured":"J Traub. Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure. 2022, 9: 2626-2634.","journal-title":"ESC Hear Fail"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jchf.2022.09.006","article-title":"Plasma Amyloid-beta in Relation to Cardiac Function and Risk of Heart Failure in General Population","volume":"11","author":"F Zhu","year":"2023","unstructured":"F Zhu. Plasma Amyloid-beta in Relation to Cardiac Function and Risk of Heart Failure in General Population. 2023, 11: 93-102.","journal-title":"JACC Heart Fail"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1212\/WNL.98.18_supplement.1718","article-title":"Association of Plasma NfL Levels with Risk of Cardiovascular Disease in the Framingham Heart Study","volume":"98","author":"H Aparicio","year":"2022","unstructured":"H Aparicio. Association of Plasma NfL Levels with Risk of Cardiovascular Disease in the Framingham Heart Study. 2022, 98: 1718.","journal-title":"Neurology"},{"key":"ref56","first-page":"227","article-title":"Cognitive impairment and its association with circulating biomarkers in patients with acute decompensated heart failure","volume":"19","author":"YC Tung","year":"2022","unstructured":"YC Tung. Cognitive impairment and its association with circulating biomarkers in patients with acute decompensated heart failure. 2022, 19: 227-237.","journal-title":"J Geriatr Cardiol;"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3233\/JAD-231096","article-title":"Alzheimer\u2019s Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis","volume":"98","author":"C Trieu","year":"2024","unstructured":"C Trieu. Alzheimer\u2019s Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis. 2024, 98: 987-1000.","journal-title":"J Alzheimers Dis;"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jchf.2024.03.005","article-title":"Serum markers of neurodegeneration are strongly linked to heart failure severity and outcome","volume":"12","author":"R Wurm","year":"2024","unstructured":"R Wurm. Serum markers of neurodegeneration are strongly linked to heart failure severity and outcome. 2024, 12: 1073-1085.","journal-title":"JACC Heart Fail"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e038860","DOI":"10.1161\/JAHA.124.038860","article-title":"Neuroglial biomarkers for risk assessment of ischemic stroke and other cardiovascular events in patients with atrial fibrillation not receiving oral anticoagulation","volume":"14","author":"J Aulin","year":"2025","unstructured":"J Aulin. Neuroglial biomarkers for risk assessment of ischemic stroke and other cardiovascular events in patients with atrial fibrillation not receiving oral anticoagulation. 2025, 14: e038860.","journal-title":"J Am Heart Assoc"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3928\/0098-9134-19990501-08","article-title":"The Mini Mental State Examination (MMSE)","volume":"7","author":"L Kurlowicz","year":"1999","unstructured":"L Kurlowicz. The Mini Mental State Examination (MMSE). 1999, 7: 62.","journal-title":"Director"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","article-title":"A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients","volume":"23","author":"E Pfeiffer","year":"1975","unstructured":"E Pfeiffer. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. 1975, 23: 433-441.","journal-title":"J Am Geriatr Soc;"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/09084282.2010.525118","article-title":"Neuropsychological Assessment Battery (NAB): Performance in a sample of patients with moderate-to-severe traumatic brain injury","volume":"17","author":"DJ Zgaljardic","year":"2010","unstructured":"DJ Zgaljardic. Neuropsychological Assessment Battery (NAB): Performance in a sample of patients with moderate-to-severe traumatic brain injury. 2010, 17: 283-288.","journal-title":"Appl Neuropsychol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1212\/WNL.0000000000206019","article-title":"Elevated Plasma Ptau Is Associated with Congestive Heart Failure (Abstract)","volume":"102","author":"J Tanner","year":"2024","unstructured":"J Tanner. Elevated Plasma Ptau Is Associated with Congestive Heart Failure (Abstract). 2024, 102: 5758.","journal-title":"Neurology"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e030780","DOI":"10.1161\/JAHA.123.030780","article-title":"Cardiovascular Disease and Alzheimer\u2019s Disease: The Heart-Brain Axis","volume":"12","author":"A Saeed","year":"2023","unstructured":"A Saeed. Cardiovascular Disease and Alzheimer\u2019s Disease: The Heart-Brain Axis. 2023, 12: e030780.","journal-title":"J Am Heart Assoc;"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"A\u03b2 amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: Mind the Heart","volume":"68","author":"L Troncone","year":"2016","unstructured":"L Troncone. A\u03b2 amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: Mind the Heart. 2016, 68: 2395-407.","journal-title":"J Am Coll Cardiol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11886-020-01318-w","article-title":"Heart and brain: complex relationships for left ventricular dysfunction","volume":"22","author":"G Daniele","year":"2020","unstructured":"G Daniele. Heart and brain: complex relationships for left ventricular dysfunction. 2020, 22: 72.","journal-title":"Curr Cardiol Rep;"},{"key":"ref67","first-page":"i","article-title":"Presenilins and early-onset familial Alzheimer\u2019s disease","volume":"8","author":"HA Rohan de Silva","year":"1997","unstructured":"HA Rohan de Silva. Presenilins and early-onset familial Alzheimer\u2019s disease. 1997, 8: i-xii.","journal-title":"Neuroreport"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.11.013","author":"","unstructured":"","journal-title":"null"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","article-title":"APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1","volume":"129","author":"M Tachibana","year":"2019","unstructured":"M Tachibana. APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1. 2019, 129: 1272-1277.","journal-title":"J Clin Invest"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"e104608","DOI":"10.1371\/journal.pone.0104608","article-title":"Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction","volume":"9","author":"H Xu","year":"2014","unstructured":"H Xu. Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction. 2014, 9: e104608.","journal-title":"PLoS One"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/CIRCRESAHA.123.323921","article-title":"Apolipoprotein E-\u03b52 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study","volume":"134","author":"R Toribio-Fern\u00e1ndez","year":"2024","unstructured":"R Toribio-Fern\u00e1ndez. Apolipoprotein E-\u03b52 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study. 2024, 134: 411-424.","journal-title":"Circ Res"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"9688","DOI":"10.3390\/ijms22189688","article-title":"Apolipoprotein E4 is associated with right ventricular dysfunction in dilated cardiomyopathy-an animal and in-human comparative study","volume":"22","author":"R Diaconu","year":"2021","unstructured":"R Diaconu. Apolipoprotein E4 is associated with right ventricular dysfunction in dilated cardiomyopathy-an animal and in-human comparative study. 2021, 22: 9688.","journal-title":"Int J Mol Sci"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.10.022","author":"","unstructured":"","journal-title":"null"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2020.4986","article-title":"Longitudinal associations of blood phosphorylated Tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease","volume":"78","author":"A Moscoso","year":"2021","unstructured":"A Moscoso. Longitudinal associations of blood phosphorylated Tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease. 2021, 78: 396-406.","journal-title":"JAMA Neurol;"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","article-title":"Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain","volume":"143","author":"E Drummond","year":"2020","unstructured":"E Drummond. Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. 2020, 143: 2803-2817.","journal-title":"Brain;"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/hmg\/ddx381","article-title":"Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"R Kandimalla","year":"2018","unstructured":"R Kandimalla. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease. 2018, 27: 30-40.","journal-title":"Hum Mol Genet"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1007\/s12035-020-02084-0","article-title":"The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer\u2019s Disease","volume":"57","author":"S Guha","year":"2020","unstructured":"S Guha. The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer\u2019s Disease. 2020, 57: 5103-5120.","journal-title":"Mol Neurobiol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/13872877251322196","article-title":"Synergistic associations of amyloid-\u03b2 and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer\u2019s disease","volume":"104","author":"C Zhang","year":"2025","unstructured":"C Zhang. Synergistic associations of amyloid-\u03b2 and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer\u2019s disease. 2025, 104: 1036-1044.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41569-022-00692-y","article-title":"The microtubule cytoskeleton in cardiac mechanics and heart failure","volume":"19","author":"MA Caporizzo","year":"2022","unstructured":"MA Caporizzo. The microtubule cytoskeleton in cardiac mechanics and heart failure. 2022, 19: 364-78.","journal-title":"Nat Rev Cardiol;"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"117229","DOI":"10.1016\/j.jns.2020.117229","article-title":"The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review","volume":"420","author":"S Ramani","year":"2021","unstructured":"S Ramani. The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review. 2021, 420: 117229.","journal-title":"J Neurol Sci"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1093\/cvr\/cvad093","article-title":"Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure","volume":"119","author":"CD Smart","year":"2023","unstructured":"CD Smart. Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure. 2023, 119: 2312-2328.","journal-title":"Cardiovasc Res"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/14728222.2017.1321635","article-title":"Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries","volume":"21","author":"KK Wang","year":"2017","unstructured":"KK Wang. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries. 2017, 21: 627-638.","journal-title":"Expert Opin Ther Targets"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"174045","DOI":"10.1016\/j.ejphar.2021.174045","article-title":"UCHL1 inhibition attenuates cardiac fibrosis via modulation of nuclear factor-\u03baB signaling in fibroblasts","volume":"900","author":"Z Gong","year":"2021","unstructured":"Z Gong. UCHL1 inhibition attenuates cardiac fibrosis via modulation of nuclear factor-\u03baB signaling in fibroblasts. 2021, 900: 174045.","journal-title":"Eur J Pharmacol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67746-4","author":"","unstructured":"","journal-title":"null"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"102295","DOI":"10.1016\/j.redox.2022.102295","article-title":"UCHL1 protects against ischemic heart injury via activating HIF-1\u03b1 signal pathway","volume":"52","author":"B Geng","year":"2022","unstructured":"B Geng. UCHL1 protects against ischemic heart injury via activating HIF-1\u03b1 signal pathway. 2022, 52: 102295.","journal-title":"Redox Biol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18050920","author":"","unstructured":"","journal-title":"null"},{"key":"ref87","first-page":"172","article-title":"Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer","volume":"53","author":"JS Johansen","year":"2006","unstructured":"JS Johansen. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. 2006, 53: 172-209.","journal-title":"Dan Med Bull"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:12:00Z","timestamp":1778742720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2026.03.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2026.03.001","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}